Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Laé

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patientsM Laé, J Couturier, S Oudard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 13, 2015
Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast?M Laé, A Lebel, F Hamel-Viard, et al.
Gastroenterologie Clinique Et Biologique|March 10, 2009
[Desmoplastic small round cell tumour of the pancreas with breast metastasis]C Neuzillet, P Hammel, A Couvelard, et al.
The Journal of Pathology|October 16, 2008
The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor geneC Filion, T Motoi, A B Olshen, et al.
The Journal of Pathology|May 2, 2007
Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomasM Laé, E H Ahn, G E Mercado, et al.
Plos One|February 2, 2016
Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based AssayD Mouttet, M Laé, M Caly, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 16, 2009
[Management of malignant phyllodes tumors of the breast: the experience of the Institut Curie]S Haberer, M Laé, V Seegers, et al.
Oncogene|October 20, 2010
Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor developmentG Sugano, I Bernard-Pierrot, M Laé, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 3, 2025
Radiation-associated angiosarcoma of the breast: consider chemotherapyA Michot, A Giraud, M Karanian, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patientsM Laé, J Couturier, S Oudard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 13, 2015
Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast?M Laé, A Lebel, F Hamel-Viard, et al.
Gastroenterologie Clinique Et Biologique|March 10, 2009
[Desmoplastic small round cell tumour of the pancreas with breast metastasis]C Neuzillet, P Hammel, A Couvelard, et al.
The Journal of Pathology|October 16, 2008
The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor geneC Filion, T Motoi, A B Olshen, et al.
The Journal of Pathology|May 2, 2007
Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomasM Laé, E H Ahn, G E Mercado, et al.
Plos One|February 2, 2016
Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based AssayD Mouttet, M Laé, M Caly, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 16, 2009
[Management of malignant phyllodes tumors of the breast: the experience of the Institut Curie]S Haberer, M Laé, V Seegers, et al.
Oncogene|October 20, 2010
Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor developmentG Sugano, I Bernard-Pierrot, M Laé, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 3, 2025
Radiation-associated angiosarcoma of the breast: consider chemotherapyA Michot, A Giraud, M Karanian, et al.
Pageof 1